Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis

Sean M. Murphy, Philip J. Jeng, Kathryn E. McCollister, Jared A. Leff, Ali Jalali, Matisyahu Shulman, Joshua D. Lee, Edward V. Nunes, Patricia Novo, John Rotrosen, Bruce R. Schackman

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences